标题:Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review
作者:Cheng-Ming Li;Zhi-Chao Liu;You-Ting Bao;Xin-Dong Sun;Lin-Lin Wang
作者机构:[Cheng-Ming Li;Zhi-Chao Liu;You-Ting Bao;Xin-Dong Sun;Lin-Lin Wang]School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medic 更多
通讯作者:Wang, LL
通讯作者地址:[Wang, LL]Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.
来源:世界胃肠病学杂志:英文版
出版年:2017
卷:23
期:41
页码:7478-7488
DOI:10.3748/wjg.v23.i41.7478
关键词:Anti-angiogenesis; Apatinib; Pancreatic cancer; Targeted therapy;; Vascular endothelial growth factor receptor-2
摘要:Chemotherapy has limited efficacy in the treatment of advanced and metastatic pancreatic cancer(PC), and has serious side effects. The development of novel effective agents, especially targeted therapy, is essential for patients with PC. We present a 58-year-old Chinese woman initially diagnosed with locally advanced PC. As the disease progressed to Stage Ⅳ, the patient was unable to tolerate chemotherapy after the fourth-line treatment. She was then treated with apatinib, a novel and highly selective tyrosine kinase inhibitor of vascular endothelial growth factor receptor-2 and achieved a progression-free-survival of 7 mo. All drug-related side effects were well controlled with medication. To the best of our knowledge, this is the first case of PC which responded to apatinib. Considering this remarkable response, apatinib may be a promising agent in the treatment of PC. We also reviewed the literature on chemotherapy and targeted therapy, especially the anti-angiogenesis therapy for patients with PC, and investigated the effect of apatinib in other solid tumors as well.
收录类别:SCOPUS;SCIE
WOS核心被引频次:2
Scopus被引频次:1
资源类型:期刊论文
原文链接:http://lib.cqvip.com/qk/84123X/201741/90888889504849555249484953.html
TOP